Dr. Schwab is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
Genentech
1 Dna Way
South San Francisco, CA 94080
Summary
- I am a medical oncologist with 16 years experience treating patients with breast cancer and conducting academic clinical research. I have taken my expertise to Genentech where I continue to focus on improving outcomes for patients with breast cancer, now entirely focused on developing new, better medications to treat this disease.
Education & Training
University of California (San Diego) Medical CenterFellowship, Hematology and Medical Oncology, 2003 - 2006- University of California (San Diego) Medical CenterResidency, Internal Medicine, 2000 - 2003
Albert Einstein College of MedicineClass of 2000
University of California, BerkeleyBA, Molecular Cell Biology, 1991 - 1995
Certifications & Licensure
CA State Medical License 2001 - 2025- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- Early Clinical Trials Award “A Biomarker Study of Mifepristone in Early Stage Breast Cancer.” UCSD Moores Cancer Center, 2010-2011
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2011-2013
Clinical Trials
- I-SPY TRIAL: Neoadjuvant and Personalized Adaptive Novel Agents to Treat Breast Cancer Start of enrollment: 2010 Mar 01
Publications & Presentations
PubMed
- 89 citationsGenome-wide mutational landscape of mucinous carcinomatosis peritonei of appendiceal origin.Hakan Alakus, Michele L. Babicky, Pradipta Ghosh, Shawn Yost, Kristen Jepsen
Genome Medicine. 2014-05-29 - 258 citationsReproductive risk factors and breast cancer subtypes: a review of the literatureKristin Anderson, Richard Schwab, Maria Elena Martinez
Breast Cancer Research and Treatment. 2014-01-30 - 105 citationsNrf2 responses and the therapeutic selectivity of electrophilic compounds in chronic lymphocytic leukemiaRaymond Wu, Tomoko Hayashi, Howard B. Cottam, Guangyi Jin, Shiyin Yao
Proceedings of the National Academy of Sciences of the United States of America. 2010-04-20
Press Mentions
Talking Breast Cancer for Men’s Health Awareness WeekJune 14th, 2017
Molecular Tumor Board Helps in Advanced Cancer CasesMay 5th, 2014
Committees
- Clinic Medical Director, UC San Diego Moores Cancer Center 2016 - Present
- UCSD Chair, Internal Advisory Committee, SDSU/UCSD Cancer Center Comprehensive Partnership 2016 - Present
- Occult Primary, NCCN Guidelines Committee Member 2014 - Present
- OPT-822 (Globo H-KLH) Phase II/III Study, Steering Committee Member 2012 - Present
External Links
- UC San Diego Healthhttp://providers.ucsd.edu/details/11447/richard-schwab-cancer-hematology_blood_diseases-la_jolla
- UC San Diegohttp://profiles.ucsd.edu/richard.schwab
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
